This Seed funding allows Holoclara to continue development of their immunotherapy to bring relief to millions of people suffering...
Read moreWe are pleased to announce that Neuro-Bio is the latest company to join the Kairos portfolio, following our investment...
Read moreWe are delighted to announce that Nikos Iatropoulos will be joining the Kairos team as Head of Operations. In...
Read moreWe would like to extend a warm welcome to three new Investment Associates joining the Kairos team: Adnan Husain,...
Read moreWe are delighted to announce that our portfolio company Delpor has been issued another patent by the United States...
Read moreCongratulations to our portfolio company Delpor for receiving a new grant award from the National Institute of Mental Health. The...
Read moreWe are very excited to announce that Behavioral Signals has joined the Kairos portfolio, following our investment in their...
Read moreCaltech researchers and collaborators, led by Axial Scientific Founder Dr. Sarkis Mazmanian, show for the first time that gut...
Read moreAxial Biotherapeutics today announced the launch of the Company with a $19.15 million Series A round of financing. The...
Read moreEsteemed primatologist, ethologist, and anthropologist Jane Goodall endorses Provivi for its contribution to helping meet the UN’s food production...
Read more